Related by context. Frequent words. (Click for all words.) 67 recurrent glioblastoma multiforme 67 Initiate Phase 66 ongoing Phase 1b 65 Amrubicin 65 phase Ib 65 phase IIb clinical 65 Phase Ib II 65 Pivotal Phase III 64 metastatic castration resistant 64 SUCCEED trial 64 Meets Primary Endpoint 64 Initiates Phase II 63 Plicera 63 HER2 positive metastatic breast 63 R sorafenib tablets 63 metastatic castrate resistant 63 Dasatinib 63 refractory chronic lymphocytic 63 sunitinib malate 63 HGS ETR2 63 multiple myeloma MM 63 Epratuzumab 62 PEG SN# 62 recurrent glioblastoma 62 glufosfamide 62 CIMZIA TM 62 phase IIa clinical 62 Eculizumab 62 ThermoDox R 61 teriflunomide 61 Commences Phase 61 metastatic renal cell carcinoma 61 proteasome inhibitor 61 forodesine 61 gastrointestinal stromal tumors GIST 61 liposomal formulation 61 Proxinium TM 61 phase IIa 61 Daclizumab 61 Aliskiren 61 metastatic hormone refractory 61 Phase Ib IIa 61 Pivotal Phase 61 castrate resistant prostate cancer 61 romidepsin 61 Receives Orphan Drug Designation 61 systemically administered 60 relapsed refractory multiple myeloma 60 Pirfenidone 60 Phase IIIb 60 Pivotal Trial 60 Presents Positive 60 multicenter Phase 60 Completes Enrollment 60 hepatocellular cancer 60 plus dexamethasone 60 pegylated interferon alpha 60 docetaxel chemotherapy 60 GVAX R 60 Phase Ib clinical 60 Phase 2a trial 60 Clinical Trial Results 60 mRCC 60 Phase Ia 60 II Clinical Trial 60 mCRC patients 60 AEG# 60 REGN# 60 plus gemcitabine 60 TELCYTA 60 Pivotal Study 60 zalutumumab 60 dose escalation clinical 60 Myelofibrosis 60 pancreatic adenocarcinoma 60 GRNVAC1 60 IIa clinical trial 60 relapsing multiple sclerosis 60 CR# vcMMAE 60 Mipomersen 60 preclinical efficacy 59 Ixempra 59 bosutinib 59 KNS # 59 acute promyelocytic leukemia APL 59 TTR amyloidosis 59 Phase III Trial 59 Irinotecan 59 Pralatrexate 59 Metastatic Melanoma 59 gastrointestinal mucositis 59 enzastaurin 59 Tesetaxel 59 ganetespib 59 Sapacitabine 59 CD# expressing 59 Allovectin 7 ® 59 TELINTRA 59 rilonacept 59 Metastatic Colorectal Cancer 59 axitinib